Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sullivan, J. B.
Right arrow Articles by Peterson, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sullivan, J. B., Jr.
Right arrow Articles by Peterson, R. G.
NEUROLOGY 1981;31:621
© 1981 American Academy of Neurology

Acute carbamazepine toxicity resulting from overdose

John B. Sullivan, Jr., M.D., Barry H. Rumack, M.D. and Robert G. Peterson, M.D., Ph.D.

University of Colorado Health Sciences Center School of' Medicine (Drs. Sullivan, Rumack, and Peterson), the B. F. Stolinsky Laboratories (Dr. Rumack), and the Rocky Mountain Poison Center (Drs. Sullivan and Rumack), Denver General Hospital, Denver, Co.

Four patients with an acute overdose of carbamazepine were examined with serial blood level determinations. The clinical spectrum consisted of coma, respiratory depression, seizures, myoclonus, nystagmus, hyperreflexia, hyporeflexia, delayed gastric emptying with cyclic coma, ataxia, sinus tachycardia, and atrioventricular conduction delay. Carbamazepine elimination half-lives varied from 10 to 29 hours, and in one case carbamazepine-l0, 11-epoxide was measured and had a half-life of 24 hours.

Address correspondence and reprint requests to Dr. Sullivan, Assistant Professor of Pediatrics, Emergency Department, University of Colorado Health Sciences Center, Box B-212,4200 East Ninth Avenue, Denver, Co 80262.

This work was supported in part by Grant No. NIGMS 2531503 and a grant from McNeil Consumer Products Company, Fort Washington, PA.

Accepted for publication July 29, 1980.




This article has been cited by other articles:


Home page
Arch NeurolHome page
A. McKeon, S. J. Pittock, G. A. Glass, K. A. Josephs, J. H. Bower, V. A. Lennon, and J. E. Ahlskog
Whole-Body Tremulousness: Isolated Generalized Polymyoclonus
Arch Neurol, September 1, 2007; 64(9): 1318 - 1322.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
M. E. Matos, M. M. Burns, and M. W. Shannon
False-Positive Tricyclic Antidepressant Drug Screen Results Leading to the Diagnosis of Carbamazepine Intoxication
Pediatrics, May 1, 2000; 105(5): 66e - 66.
[Abstract] [Full Text]


Home page
Hum Exp ToxicolHome page
R.S. Howard, P. StJ. Trend, and H.R.A. Townsend
EEG Appearances in Acute Carbamazepine Toxicity
Human and Experimental Toxicology, January 1, 1990; 9(5): 313 - 315.
[Abstract] [PDF]


Home page
Hum Exp ToxicolHome page
P.N. Patsalos, S. Krishna, A.A. Elyas, and P.T. Lascelles
Carbamazepine and Carbamazepine-10,11-epoxide Pharmacokinetics in an Overdose Patient
Human and Experimental Toxicology, May 1, 1987; 6(3): 241 - 244.
[Abstract] [PDF]


Home page
Hum Exp ToxicolHome page
D.W. Denning, L. Matheson, S.M. Bryson, J. Streete, D.J. Berry, and J.A. Henry
Death Due to Carbamazepine Self-poisoning: Remedies Reviewed
Human and Experimental Toxicology, May 1, 1985; 4(3): 255 - 260.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by AAN Enterprises, Inc.